• Clinical and Translational Science

• Rare Disease Research and Therapeutics

• Re-engineering Translational Sciences
• . NIH Chemical Genomics Center
  • . Molecular Libraries Probe Production Center
    • . Molecular Libraries Probe Production Center Projects
  • . Assay Development and High-Throughput Screening
    • . High-Throughput Screening Assay Guidance Criteria
    • . Assay Development and High-Throughput Screening Projects
  • . Chemistry Technology
    • . Chemistry Technology Projects
  • . RNAi
    • . RNAi Projects
• . Rescuing and Repurposing Drugs
  • . Discovering New Therapeutic Uses for Existing Molecules
    • . Therapeutics Discovery Funding Information
    • . Template Agreements
    • . Library of Industry-Provided Agents
    • . FAQ About Therapeutics Discovery
    • . Trans-NIH Therapeutics Discovery Contacts
  • . NCATS Teams Up with Eli Lilly
• . Tissue Chip for Drug Screening
  • . Tissue Chip Funding Information
  • . 2012 Tissue Chip Project Awards
    • . Tissue Chip Awards: Cell Resources
    • . Tissue Chip Awards: Model Systems
• . Identifying and Validating Drug Targets
• . Toxicology in the 21st Century
  • . Tox21 Projects

• Strategic Alliances for Technology Transfer

• Program Index

• Tools for Researchers

• Scientific Publications

Tox21 Projects

Tox21 projects are made possible by new technologies and new discoveries in gene expression analysis, culture of human tissue stem cells and integrated pathway information.

Selected Tox21 projects:

• Profiling of Environmental Chemicals on Nuclear Receptors
• The Future Testing of Compound Toxicity Using a Robotic System

Social Media Links

• Contact Us
• Bookmark & Share
• Twitter
• Facebook
• YouTube

Page Footer

• NCATS Home
• Site Map
• Privacy Notice
• Disclaimer
• Accessibility
• FOIA
• OIG
• FAQ

National Center for Advancing Translational Sciences (NCATS), 6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-435-0888